1 citations
,
May 2022 in “Reproductive Endocrinology” This review discusses the complexities of diagnosing and managing hyperandrogenism in women, emphasizing the need for careful evaluation of both clinical signs and biochemical markers without reporting new clinical results.
1 citations
,
November 2015 in “Journal of Evolution of Medical and Dental Sciences” This study observed that certain skin symptoms in SLE, such as malar rash and photosensitivity, are linked to systemic involvement, indicating their potential role as markers for disease activity.
1 citations
,
December 2005 in “Al-Mağallaẗ al-ʻirāqiyyaẗ li-l-ṣaydalaẗ” In this clinical study, melatonin treatment reduced oxidative stress markers and enhanced hair growth in patients with alopecia areata, potentially through its effects on the immune system and antioxidant activity.
1 citations
,
July 2003 in “Hair transplant forum international” The document's conclusion cannot be provided because the document is not accessible or understandable.
This chapter reviews various metrics for measuring sales performance, including sales effectiveness, market share, customer retention, and more, but reports no new research findings.
August 2026 in “Journal of Ayurveda and Integrated Medical Sciences” This case study of a 43-year-old woman with primary hypothyroidism found that an integrated Ayurvedic treatment over 20 weeks led to normalized thyroid function and relief of hypothyroid symptoms, highlighting Ayurvedic therapy's potential role in managing the condition.
June 2026 in “Journal of Cosmetic Dermatology” This study found that a combined treatment using autologous scalp‐derived micrografts and allogeneic dental pulp stem cell‐derived conditioned medium was well-tolerated and improved hair characteristics in 69.5% of patients with male androgenetic alopecia, particularly increasing hair diameter and hair number per follicular unit.
May 2026 in “International Journal of Drug Delivery Technology” This study investigated a herbal extract combining Emblica officinalis with 2% minoxidil solution for hair growth and found it significantly enhanced follicular size and prolonged hair growth phases, suggesting it may be an effective hair growth treatment compared to standard minoxidil solutions.
May 2026 in “Journal of Clinical Oncology” This study found that nearly 40% of Hodgkin’s Lymphoma patients who received Brentuximab Vedotin with AVD chemotherapy experienced persistent alopecia more than two years after treatment, leading to significant psychosocial consequences such as reduced self-confidence and emotional distress.
April 2026 in “Diagnostics” This study found that skin changes in morbidly obese individuals are associated with underlying metabolic disturbances but are not currently valuable as independent tools for assessing metabolic risk or treatment response.
In this study, the researchers analyzed skin samples from Dun Mongolian horses to uncover molecular pathways linked to the "Bider" marking, identifying differential gene expression and several pigment-related signaling pathways that may play key roles in its formation.
February 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review evaluates the efficacy and safety of natural hair growth actives set to enter the 2025–2026 market, noting their potential as alternatives to conventional therapies for alopecia but highlighting formulation challenges that may impact their effectiveness.
February 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review critically evaluated natural hair growth actives for the 2025–2026 marketplace and found they show potential as alternatives to conventional therapies for androgenetic alopecia, with favorable safety and patient acceptance, though challenges such as formulation instability and limited follicular penetration remain.
December 2025 in “Indian Journal of Case Reports” This case report highlights an unusual instance of azathioprine potentially triggering rapid alopecia areata and bone marrow suppression in a patient with chronic spontaneous urticaria, with improvement seen after stopping the drug.
December 2025 in “Biology Bulletin Reviews” This research review highlights how hair cortisol concentration can reflect the activation of the stress-response system in farm, domestic, and wild animals, noting it correlates with factors like species, sex, age, and environmental conditions, which may influence stress and adaptation.
October 2025 in “Scientific Reports” In this study of 131 healthy men aged 30 to 45, no relationship was found between androgen receptor gene polymorphisms related to androgen sensitivity and biological age markers, suggesting that other factors may influence the aging process independently of these genetic variations.
September 2025 in “Dietary Supplements and Nutraceuticals” In this study, the authors reported that Cerebronal® supplementation for three to six months may modulate certain biomarkers associated with neurodegeneration and brain repair in individuals with memory problems.
August 2025 in “Journal of Medical and Life Science” This case-control study in Missan Province, Iraq, found that married women with PCOS had higher rates of obesity and menstrual irregularities, along with elevated testosterone, LH, and insulin levels, compared to healthy controls, highlighting significant hormonal and metabolic complications.
July 2025 in “Clinical Dermatology Review” This report presents a rare case where a patient with chronic urticaria developed alopecia areata during azathioprine therapy, accompanied by bone marrow suppression; these effects resolved after stopping the medication, suggesting a possible link between azathioprine and autoimmune activation despite its intended immunosuppressive use.
June 2025 in “International Journal for Research in Applied Science and Engineering Technology” This study evaluated the physicochemical properties of an herbal shampoo formulated with natural ingredients like hibiscus and henna and compared it to a common marketed shampoo, finding it effectively replaced some chemical components with safer alternatives while maintaining similar characteristics.
March 2025 in “Clinical Cosmetic and Investigational Dermatology” In this study, researchers found that the "U" allele of the Tru9I variant may be associated with low vitamin D levels and altered VDR gene activity in alopecia areata patients, while the "u" allele might have a protective role against developing the condition.
January 2025 in “Open Science Framework” This abstract outlines the genetic and biological processes of hair growth, highlighting that various hair disorders can have significant medical, aesthetic, and psychological impacts, though specific research findings or results were not reported.
January 2025 in “International Journal of Herbal Medicine” In this case study, a 27-year-old male with premature greying of hair saw significant improvement in hair whitening after ten weeks of treatment with Unani formulations, despite no family history or systemic disorder.
December 2024 in “Skin Appendage Disorders” Traction alopecia reduces hair density and thickness; proper hair care can help prevent it.
July 2024 in “The Egyptian Journal of Hospital Medicine” In this study, researchers observed that serum calprotectin levels were higher in alopecia areata patients compared to controls, yet this difference was not statistically significant, and calprotectin was not a reliable predictor of disease activity in alopecia areata patients.
May 2024 in “International journal of medicine and psychology.” In this study, researchers observed that transcranial electrical stimulation in COVID-19 patients with mild to moderate symptoms led to a trend of greater reduction in interleukin-10 levels and interleukin-10/lymphocyte ratio compared to standard treatment alone, suggesting potential impacts on immunosuppression mechanisms that warrant further investigation.
April 2024 in “Russian Journal of Preventive Medicine” This review discusses how skin changes like acanthosis nigricans and psoriasis can indicate metabolic syndrome components such as insulin resistance and dyslipidemia, suggesting a potential role for early diagnosis and treatment in reducing cardiovascular risks associated with the syndrome.
January 2024 in “Fitoterapia” In this study, the analysis of Ukraine's pharmaceutical market from 2020 to 2023 found a large variety of Vitamin D3 preparations, predominantly domestic and synthetic, with capsule forms being common; consumer surveys highlighted that doctor recommendations strongly influenced purchasing decisions.
July 2023 in “International Journal of Molecular Sciences” This study found that N,N-dimethylglycine sodium salt promoted proliferation and migration of cultured human epidermal keratinocytes and had anti-inflammatory and antioxidant effects in vitro.
July 2023 in “International journal of dermatology, venereology and leprosy sciences” This review discusses micro needling as a therapeutic option for various dermatological conditions, such as scars and pigmentation, and reports no new clinical results; the authors note potential side effects and contraindications.